Atlas Trials

Vaccine Study for Surgically Resected Pancreatic Cancer

Clinical trial NCT00569387 · COMPLETED

Trial details

NCT number
NCT00569387
Sponsor
NewLink Genetics Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2007-12-01
Primary completion
2011-03-01
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.